Fujieda Megumi, Maeda Akiko, Kondo Kyoko, Fukushima Wakaba, Ohfuji Satoko, Kaji Masaro, Hirota Yoshio
Department of Public Health, Osaka City University Faculty of Medicine, Asahi-machi 1-4-3, Osaka 545-8585, Japan.
Vaccine. 2008 Nov 25;26(50):6481-5. doi: 10.1016/j.vaccine.2008.06.034. Epub 2008 Jun 23.
This study, done during the 2002--2003 season among children <6 years of age to investigate influenza vaccine effectiveness and confounding factors, involved 2913 children (1512 vaccinees, 1401 non-vaccinees) recruited from 54 paediatric clinics. Between December 2002 and April 2003, parents reported their children's maximum body temperatures weekly. Influenza-like illness (ILI) was defined as an acute febrile illness (> or =38.0 degrees C) during the peak epidemic period. Adjusted odds ratios (ORs) for ILI were obtained using a logistic regression model. In analysis for total subjects, the ORs were significantly decreased for vaccinees (OR: 0.76, 95% CI: 0.66-0.88) and significantly increased for younger age groups, including children aged 2.0-3.9 years (1.42, 1.18-1.72) and those < 2.0 years (2.02,1.61-2.54), compared to those between 4.0 and 5.9 years. ORs were significantly increased for children who visited a physician within the last 6 months for a cold (1.27, 1.08-1.50), attended preschool (1.72, 1.45-2.04), and had > or =3 siblings (1.42, 1.15-1.74). These confounding factors are suggested to be considered in estimating vaccine effectiveness among young children. In subgroup analysis by age groups, significantly decreased ORs were seen in 2.0-3.9-year-old (0.59, 0.47-0.74) and 4.0-5.9-year-old (0.75, 0.58-0.98) vaccinees; no significant vaccine effectiveness was detected for those < 2.0 years (1.07, 0.80-1.44). Thus, among very young children vaccine effectiveness could not be demonstrated.
这项研究于2002 - 2003年流感季节期间,针对6岁以下儿童展开,旨在调查流感疫苗的有效性及混杂因素。该研究从54家儿科诊所招募了2913名儿童(1512名接种疫苗者,1401名未接种疫苗者)。在2002年12月至2003年4月期间,家长每周报告孩子的最高体温。流感样疾病(ILI)被定义为在流行高峰期出现的急性发热疾病(体温≥38.0摄氏度)。使用逻辑回归模型获得ILI的调整比值比(OR)。在对所有受试者的分析中,接种疫苗者的OR显著降低(OR:0.76,95%置信区间:0.66 - 0.88),与4.0至5.9岁的儿童相比,包括2.0 - 3.9岁(1.42,1.18 - 1.72)和2.0岁以下(2.02,1.61 - 2.54)的儿童在内的较年轻年龄组的OR显著升高。在过去6个月内因感冒看过医生的儿童(1.27,1.08 - 1.50)、上过学前班的儿童(1.72,1.45 - 2.04)以及有≥3个兄弟姐妹的儿童(1.42,1.15 - 1.74)的OR显著升高。建议在评估幼儿疫苗有效性时考虑这些混杂因素。在按年龄组进行的亚组分析中,2.0 - 3.9岁(0.59,0.47 - 0.74)和4.0 - 5.9岁(0.75,0.58 - 0.98)的接种疫苗者的OR显著降低;对于2.0岁以下的儿童(1.07,0.80 - 1.44)未检测到显著的疫苗有效性。因此,在非常年幼的儿童中无法证明疫苗的有效性。